 |
인쇄하기
취소
|
Dong-A's Zydena grabs bigger market share
Dong-A Pharm is expanding its share of the domestic anti-impotence drug market dominated by international drug makers.
Zydena, the first-domestically-made medication for erectile dysfunction, is challenging Viagra of Pfizer. It received approval from the nation's food and drug authorities in November 2005.
According to Dong-A, Zydena's market share took 22.6 percent in the third quarter...
Zydena, the first-domestically-made medication for erectile dysfunction, is challenging Viagra of Pfizer. It received approval from the nation's food and drug authorities in November 2005.
According to Dong-A, Zydena's market share took 22.6 percent in the third quarter...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.